Joe B. Putnam, Jr., M.D. Rev. October2013

CURRICULUM VITAE

NAME:Joe B. Putnam, Jr., M.D.

OFFICE ADDRESS:Department of Thoracic Surgery

VanderbiltUniversityMedicalCenter

609 Oxford House

1313 21st Avenue South

Nashville, TN 37232–4682

Phone: (615) 343-9202

Fax: (615) 322-3079

E - mail:

Thoracic Surgery

c/o Surgical Services

NashvilleVAMedicalCenter

VA TennesseeValley Health Care System (TVHS)

1310 24th Avenue South

Nashville, Tennessee 37212 - 2637

Phone: (615) 327 - 5356 x 5615

Hospital: (615) 327 - 4751

Fax: (615) 321 - 6342

CITIZENSHIP:USA

Military or Other Governmental Service

Director of Surgical Services, Naval ReserveCombatZoneFleetHospital 21,

Dallas, TX1997 - 1998

Head, Division of Cardiothoracic Surgery, Naval Hospital - San Diego, CA

OPERATION DESERT STORM 1990 - 1991

Navy Commendation Medal1991

Captain (O-6, retired), Medical Corps, United States Naval Reserve1985 - 2011

PRESENT TITLE AND AFFILIATION:

Primary AppointmentProfessor of Surgery and Chairman

Ingram Professor of Cancer Research

Department of Thoracic Surgery

VanderbiltUniversityMedicalCenter

Nashville, TN

Secondary AppointmentProfessor of Biomedical Informatics

Department of Biomedical Informatics

VanderbiltUniversityMedicalCenter

Nashville, TN

EDUCATION:

Postgraduate Education and Training

Resident in Thoracic Surgery, University of Michigan, Ann Arbor, MI 1986 - 1988

Chief Resident in Surgery, University of RochesterSchool of Medicine

and Dentistry, Rochester, NY1985 - 1986

Senior Assistant Resident in Surgery, University of RochesterSchool of Medicine

and Dentistry, Rochester, NY 1984 - 1985

Medical Staff Fellow, Surgery Branch, National Cancer Institute, National Institutes of Health,

Bethesda, MD 1981 - 1984

Junior Assistant Resident in Surgery, JohnsHopkinsHospital, Baltimore, MD1980 - 1981

Surgical Internship, JohnsHopkinsHospital, Baltimore, MD 1979 - 1980

Degree-Granting Education

The University of North Carolina at Chapel Hill, Doctor of Medicine, 1975 - 1979

The University of North Carolina at Chapel Hill, A.B. with Honors in Chemistry1971 - 1975

Additional Education

“Understanding the New World of Health Care”. JohnF.KennedySchool of Government, HarvardUniversity, November 15 - 23, 1997.

Rice Program for Managers, Rice University, School of Business, Houston, TX, January 16, 1999 - March 27, 1999.

National Comprehensive Cancer Network, NCCN Practice Guidelines for Esophageal Cancer, 2000

Finance and Budgeting for Non - Financial Healthcare Professionals, University of Texas MD Anderson Cancer Center, Houston, TX - - October 24, 2002.

AmericanCollege Surgeons, Clinical Trials Methods Course –December, 2002.

IRB Human Subjects Protections Training Program, VanderbiltUniversity Institutional Review Board, March, 2004.

Clinical Trials Program, American College of Surgeons, Chicago, IL - - June 16 - 19, 2004.

Clinical Trials Research Methods, The Society of Thoracic Surgeons and the University of Colorado; Denver CO - - August, 2004

KeckSchool of Public Health, Center for Continuing Professional Education, Program for Chiefs of Clinical Services, HarvardUniversity, Boston, MA - - January 16 - 28, 2005.

VanderbiltUniversityMedicalCenter, Academic Leadership Program, Nashville, TN - - March – December, 2005

CREDENTIALS:

Board Certification

American Board of Surgery 23087 1987

American Board of Thoracic Surgery 4870 1989 - 1999,

Recertified 1998 - 2009

Recertified 2008 - 2019

Licensures Expiration Dates

North Carolina Medical Board 249839/26/15

DEA Registration BP86205713/31/16

Tennessee Board of Medical Examiners381769/30/15

EXPERIENCE/SERVICE:

Academic Appointments

Assistant Professor, Division of Thoracic and Cardiovascular Surgery,

University of TexasSchool of Medicine, Houston, TX1988 - 1994

Assistant Surgeon, Assistant Professor of Surgery, Department of Thoracic Surgery,

University of TexasM.D.AndersonCancerCenter, Houston, TX1988 - 1994

Associate Surgeon, Associate Professor of Thoracic & Cardiovascular Surgery,

Department ofThoracic & Cardiovascular Surgery,

University of TexasM.D.AndersonCancerCenter, Houston, TX1994 - 2000

Deputy Chairman, Department of Thoracic and Cardiovascular Surgery,

University of TexasM.D.AndersonCancerCenter, Houston, TX1995 - 2004

Professor of Surgery, Department of Thoracic and Cardiovascular Surgery,

University of TexasM.D.AndersonCancerCenter, Houston, TX2000 - 2004

Chief, Section of Cardiothoracic Surgery, NashvilleVAMedicalCenter,

VA TennesseeValley Health Care System (TVHS), Nashville, TN2004 - 2005

Professor of Surgery and Chairman, Department of Thoracic Surgery,

VanderbiltUniversityMedicalCenter, Nashville, TN2004 - present

AcademicAdministrative Appointments/Responsibilities

University of TexasM.D.AndersonCancerCenter

Deputy Director, Surgical Intensive Care Unit1991 - 1992

Search Committee for Chairman of the Dept. of Anesthesiology1992 - 1992

Member - Division of Surgery and Anesthesiology Promotions Committee1995 - 1997

Deputy Chair, Department of Thoracic and Cardiovascular Surgery1995 - 2004

Director, Surgical Education and Training, Department of

Thoracic and Cardiovascular Surgery1992 - 2004

Member, Division of Surgery Promotions Committee1996 - 1998

Member, Operating Room Committee1997 - 2004

Program Director, Clinical and Resident Education,

Department of Thoracic and Cardiovascular Surgery1997 - 2004

Chairman, Division of Surgery Faculty Promotions Committee 1998 - 2004

Chairman, Operating Room Subcommittee on “Correct Site/Side” Surgery2002 - 2004

Chairman, Revenue Cycle Advisory Committee2002 - 2004

Chairman, ad hoc Clinical Faculty Recognition Committee2002 - 2003

VanderbiltUniversityMedicalCenter

Program Director, Residency Program in Thoracic and Cardiac Surgery2004 - present

Member, Section of Surgical Sciences Promotion Committee2005 - present

Member, Section of Surgical Sciences Quality Control Committee2006 - present

Institutional Committee Activities

University of TexasM.D.AndersonCancerCenter

Alternate, Research Committee 1989 - 1994

Member, Conduct of Care Subcommittee 1989 - 1994

Institutional Committee Activities (cont.)

Thoracotomy Videotape Task Force 1991 - 1992

Member, Institutional Clinical Research Committee 1991 - 1992

Member, Faculty Senate By-Laws Committee 1992 - 1994

Member, Graduate Medical Education Committee 1992 - 1995

Member, Medical Practice Subcommittee of the Medical Staff1992 - 1995

Member, GI Tumor Group 1993 - 1993

Chairman, Faculty Senate Finance Committee 1993 - 1995

Member, Task Force on Incentive - based Compensation for Faculty 1994 - 1995

Member, Disaster Subcommittee of the Medical Staff 1995 - 1995

Member, Credentials Committee of the Medical Staff (CCMS) 1995 - 1996

Member, Executive Committee of the Faculty Senate1995 - 1997

Member, Executive Committee of the Medical Staff, (ECMS)1995 - 1997

Member, Conflict of Interest Committee1995 - 1998

Participant, Telemedicine Conferences, M.D.AndersonCancerCenter Orlando1995 - 2000

Member, Clinical/Technical Team - Second Opinion at a Distance/Telemedicine1997 - 1998

Member, Roster of Services Committee 1997 - 1997

Network Development/Contracting Team 1997 - 1999

Managed Care Operations Committee 1997 - 1999

Member, Guidelines & Pathways Committee 1997 - 1998

Member, Cancer Manager Project Leaders1997 - 1999

Member, Audit Committee 1997 - 2001

Member, 1997 Faculty Achievement Award Parent Committee 1997 - 2001

Member, PET Program Steering Committee 1998 - 2000

Member, Cancer Consultant Operations Committee 1998 - 1999

Co - Chairman, Committee on Faculty Peer and Grievance Review 1998 - 2000

Member, Graduate Medical Education Committee 1999 - 2004

Co - Chairman, Diagnostic Imaging Users Group Committee 1999 - 2000

Member, Physicians Referral Service Executive Committee

Elected Representative – Division of Surgery1999 - 2004

Member, Diagnostic Imaging Search Committee2000 - 2001

Conflict Management Advisory Committee2000 - 2003

Chairman, Conflict Management Advisory Committee2001 - 2002

Ombudsman Selection Committee2000 - 2001

Member, Charles LeMaistre Outstanding Achievement Award Committee2000 - 2000

Member, Promotion and Tenure Committee2000 - 2004

Chairman, GME Internal Review Sub - Committee for Pathology2002 - 2002

Member, Credentials Committee of the Medical Staff2002 - 2004

Member, Conflict of Interest Committee2002 - 2004

Member, ad hoc Committee for Review of Non - Tenured Clinical Faculty2003 - 2004

Vanderbilt University Medical Center

Member, Vanderbilt Ingram Cancer Center2004 - Present

Member, Medical Center Medical Board2004 - Present

PROFESSIONAL MEMBERSHIPS/ACTIVITIES

Professional Society Activities, with Offices Held

American Association for Thoracic Surgery:

Member, Scientific Advisory and Government Relations Committee2004 – 2012

Member, Council on Cardiothoracic Surgery2009 - 2012

Member, Thoracic Surgery Joint Workforce

Member, Tech - Con Workforce 2007 – 2008

Co - Chair, Tech - Con Workforce2007 – 2008

AHRQ/CMS Subcommittee2004 – 2007

Member, Ad Hoc Program Review Committee2009 – 2010

Professional Society Activities, with Offices Held (cont.)

American Board of Thoracic Surgery:

Director2013 – 2018

Credentials Committee2013 – 2018

Examination Committee2013 – 2018

General Thoracic Subcommittee2013 – 2018

Finance Committee2013 – 2018

American Board of Thoracic Surgery, guest examiner2004 –2011

American College of Surgeons:

Web Portal Committee2004 – 2010

Board of Governors (representing Southern Thoracic Surgical Association)2007 – present

Advisory Council for Cardiothoracic Surgery2011 – 2012

American College of Surgeons Oncology Group

Chair, Thoracic Organ Site Committee, 2002 –2010

Member, Executive Committee2002 –2010

American Society for Clinical Oncology

Member, Scientific Program Committee2008 – 2011

Member, Cancer Communications Committee2012 – 2013

American Surgical Association, Fellow2011 – 2012

Bayer Fellowships in Blood Conservation Selection Committee2005 – 2008

European Association for Cardiothoracic Surgery

General Thoracic Surgical Club

Houston Surgical Society1996 – 2004

International Association for the Study of Lung Cancer

Chair, Consensus ConferenceCommittee on Adjuvant Therapy 1993

Member, Education Committee2003

Chair, Bylaws Committee 2006 – 2007

Member, Bylaws Committee2005 – 2009

Joint Council on Thoracic Surgery Education, Assessment Committee2012

Nashville Surgical Society2005 – present

Sigma Xi (Life Member)1977 – present

Society of Thoracic Surgeons:

Member, National Database Task Force2002 – 2003

Chair, Workforce on Research and Clinical Trials2003 – 2006

Member, Workforce on Annual Meeting2007 – 2008

Co–Chair, Tech–Con Workforce2007 – 2008

Member, Workforce on Media Relations and Communications 2007 – 2013

Member, Workforce on Access and Publications2008 – 2011

Society of Surgical Oncology

Southern Surgical Association

Southern Thoracic Surgical Association

Texas Surgical Association

The John Alexander Society

UT MD Anderson Associates

American Radium Society1995 –2005

National Quality Forum Perioperative Steering Committee2008– 2010

Technical Advisory Panel 2010– 2012

Thoracic Surgery Directors Association2004– 2010Nominating Committee

Local/State

Planning Committee, Thoracic Surgery Lecture Series, Baylor College of Medicine, Department of

Cardiovascular and Thoracic Surgery, Houston, TX1996–2004.

Member, Advisory/Operations Committee for the Center of Excellence in Minimally Invasive Surgery at

Hermann Hospital, University of Texas Health Science Center at Houston1993–1994

Professional Society Activities, with Offices Held (cont.)

Co - Chair, Esophageal Cancer Session; Multidisciplinary G.I. Cancer Retreat, University of Texas M. D.

Anderson Cancer Center, Houston, TX1992

Coordinating Committee Interdisciplinary Oncology Conference, University of Texas Medical School, Houston,

TX1990–1991

Tennessee Chapter, American College of Surgeons2009–Present

Charter Member, Institute for Responsible Dispute Resolution, Houston, TX2001

National and International:

International Association for the Study of Lung Cancer

Chair, Surgery Committee, 11th World Conference on Lung Cancer, Barcelona, Spain July 2005

Chair, Bylaws Committee2005 –2007

NCI Thoracic / Lung Intergroup2003–2010

NCI GI Intergroup Esophagogastric Disease Site Working Group2004–present

Program Committee, American Association of Thoracic Surgery2004– 2006

American College of Surgeons Oncology Group (ACOSOG) 2002 –2012

Committee Member, American College of Surgeons, Commission on Cancer Disease Site Team 2002–present

Committee Member, Society of Thoracic Surgeons, National Databases Resource Group, 2002–2005

Member, Society of Thoracic Surgeons, Nomenclature and Coding 2001–2005

Member, Intergroup Lung Cancer Working Council, Randomized Trial Neoadjuvant

Chemotherapy and Surgery versus Surgery Alone for Early Stage Lung Cancer “S9900” 1998

Member, Radiation Therapy Oncology Group Thoracic Surgery Subcommittee 1989–2001

Member, National Database Committee, National Thoracic Surgery Database,

Society of Thoracic Surgeons, Chicago, IL1995–1997

Chairman, Video Thoracoscopic Surgery Session, 4th European Congress of Video Surgery,

Istanbul, Turkey 1994

Member, Original Investigators Committee, 58th Annual Scientific Assembly,

American College of Chest Physicians1991

National Cancer Institute, Thoracic Malignancies Steering Committee2008 – 2010

TEACHING

Courses Taught

Instructor Advanced Cardiac Life Support Provider Course, The University of Texas M. D. Anderson Cancer Center, 1994–1998.

Training Programs

Video - Assisted Thoracoscopy Training Course, Department of Thoracic Surgery, 1992

Coordinator, Third Year Students (Two week rotation) in Thoracic Surgery, 1988–2000

Other Educational Programs

Teaching Assistant - General Chemistry, Department of Chemistry,

University of North Carolina at Chapel Hill1974 –1975.

Student Project Director, Student Originated Studies, National Science Foundation, Department of Zoology,

University of North Carolina at Chapel Hill1988–1994

Surgical Lecture Series, Department of Surgery, University of Rochester Strong Memorial Hospital, Rochester, New York 1985–1986

Thoracic Surgery Lecture Series, Department of Thoracic Surgery, University of Texas M. D. Anderson Cancer Center 1988–1994

Instructor, Advanced Trauma Life Support Provider Courses, Southeast Trauma Educ Foundation 1994–1998

Director, Clinical Education and Training, Department of Thoracic and Cardiovascular Surgery, University of Texas M. D. Anderson Cancer Center 1996–2004

Moderator, Institutional Grand Rounds Pearls - The Art and Science of Medicine, University of Texas M. D. Anderson Cancer Center, Sep, 1999

Other Educational Programs (cont.)

Moderator, Institutional Grand Rounds Pearls - The Art and Science of Medicine, University of Texas M. D. Anderson Cancer Center Jun, 2001

Moderator, Institutional Grand Rounds Pearls - The Art and Science of Medicine, University of Texas M. D. Anderson Cancer Center Sep, 2002

Program Director, Thoracic Surgery, Vanderbilt University Medical Center, Nashville, TN 2004 – present

Contributor, 2010 NSCLCeducation.org on-demand webinar, “The New (2010) AJCCOct, 2010

Lung Cancer Staging System”

Supervisory Teaching

Direct Supervision

Undergraduate, Medical, and Allied Health Students

Graduate and Postgraduate Students

Suk - Joo Rha, M.D., Postdoctoral Fellow 1/98–12/99

Imran Mohiuddin, M.D., Researcher 1/99–12/01

Freddy Angulo, M.D., Observer 2/99– 9/00

Jin - Sun Kim, M.D., Postdoctoral Fellow7/05 – 3/08

Lori Ferranti, PhD Candidate2006 – 2009

Mentoring:

Faculty: Eric S. Lambright, M.D.2004–present

Eric L. Grogan, M.D.2008–present

Residents: Gary Hochheiser, M.D.2004

Tarek Absi, M.D.2004 –2005

Robert DuBose, M.D.2005–2007

Tammy Baxter, M.D.2006–2008

Jared Antevil, M.D.2007–2009

Alex Karavas, M.D.2008–2010

Daniel Cuadrado, M.D.2008–2012

James Mykytenko, M.D.2009 –2011

Nikhil Jaik, MB.,B.S.2010 –2012

Aaron Hoffman, M.D.2011 – 2014

Aundrea Oliver, M.D.2011 – 2014

Elena Ziarnik, M.D.2012 – 2015

Pre-Doctoral Trainee: Lori Ferranti2005 – 2009

Stephen Deppen2008 –2013

Outside of Current Institution:

Organization of National or International Conferences/Symposia

The Society of Surgical Oncology’s 49th Cancer, Thoracic Oncology Session;

Symposium, Atlanta, GA, Moderator, 1997

American Radium Society 80th Annual Meeting, Lung Cancer,

Monte Carlo, Monaco, Discussion Panel 1998

American Radium Society 80th Annual Meeting, Esophageal Cancer

Monte Carlo, Monaco, Moderator 1998

American Radium Society Program Committee, 2003

American Association for Thoracic Surgery, Program Review Committee 2003 –present

Chair, Surgery Abstract Committee, International Association for the Study of Lung

Cancer; World Congress, Barcelona, Spain 2005

RESEARCH

Grants and Contracts

Principal Investigator, A Prospective Randomized Study of Pleural Drainage vs. Tube Thoracostomy and Pleurodesis for Treatment of Pleural Effusions, Denver Biomaterials, Inc., Golden CO,

4/4/94–4/4/96, $33,750 ($16,875/year)

Principal Investigator, Ethicon Endosurgery, Residents and Fellows Training and Development, Cincinnati, OH,

5/1/94–4/30/96, $12,811 ($6,400/year)

Institutional Principal Investigator, Co - Investigator for National Study, A Multicenter Phase III Trial to Evaluate the Efficacy of Recombinant Human GM - CSF (rhu GM - CSF) for Prophylaxis of Postoperative Infection, Immunex Corporation, Seattle, WA,

4/95–4/96, $250,000 ($250,000/year)

Principal Investigator, In Vitro and in Vivo Studies to Enhance Isolated Single Lung Perfusion For the Treatment of Sarcomatous Pulmonary Metastases In a Rodent Model, University of Texas M. D. Anderson Cancer Center, Houston, TX, Physician Referral Service Research

2/1/98–1/31/99, Award $22,178 ($22,178/year)

Co - Investigator, University of Texas SPORE in Lung Cancer, NCI

9/1/98–8/31/99, $3,828,945 ($3,828,945/year)

Co - Investigator, University of Texas SPORE in Lung Cancer, NIH

9/01/99–8/31/01, $24,960 ($12,480/year)

Co - Investigator, Restoration of Apoptosis in Cancer, NIH/NCI

5/01/00–4/30/01, $690,030 ($690,030/year)

Principal Investigator, Evaluation of Radiofrequency Ablation (RFA) for Malignant Lung Tumors, Rita Medical Services, Mountain View, CA

8/10/00–8/31/01, $17,090 ($17,090/year)

Co-Investigator,Using a novel system to assess and manage post - operative pain and other symptoms in patients with lung cancer, University of Texas M. D. Anderson Cancer Center, Houston, TX

12/01/01–11/30/03, $299,884 ($149,942/year)

Institutional Principal-Investigator, A Randomized Phase III Trial Surgery Alone or Surgery Plus Preoperative Paclitaxel/Carboplatin in Clinical Stage IB (T2NO), II (T2 - 2N1, T3NO) and Selected IIIA (T3N1) Non - Small Cell Lung Cancer (NSCLC),Southwest Oncology Group (SWOG), San Antonio, TX

1/10/01–12/31/04, $256,950 ($85,650/year)

Co - Investigator, 5 U10 CA076001 05,American College of Surgeons Oncology Group, Duke University, Durham, NC 5/01/02–4/30/10, ($128,000).

Database Administrator, University of Texas SPORE in Lung Cancer, NIH

9/01/02 – 4/30/03, ($100,000) Principal Investigator

Principal Investigator, “A Multi - Center, Randomized, Double - Blind, Placebo - Controlled, Parallel Design, 2 - Arm Study to Investigate the Effect of Aprotinin on Transfusion Requirements in Patients Undergoing Surgical Procedures for Lung Cancer or Esophageal Cancer” Bayer – BAY Number BAY a 0128; Study Number11800 January 1, 2006 – December 31, 2008

Patents

#6,699,231 March 2, 2004; Sterman WD, Stevens JH, Gifford III HS, Siegel LC, Putnam, JB Jr.. Assignee: Heartport, Inc.(Redwood City, CA (appl. No, 223229; Filed December 30, 1998). “Methods and apparatus for perfusion of isolated tissue structure”.

Protocols

Collaborator, A Prospective Randomized Three - Arm Phase III Trial Comparing Trimodality Therapy Cisplatin, 5 - FU, Radiotherapy and Surgery, Adjuvant Chemotherapy (Cisplatin and 5 - FU) and Surgery Alone For Esophageal Cancer,CALGB 9X9L, University of Maryland School of Medicine, Baltimore, MD, 1995

Co - Investigator, A Phase I Study of E1A Gene Therapy for Patients with Metastatic Breast or Epithelial Ovarian Cancer that Overexpress HER - 2/neu, DM 94 - 129, University of Texas M.D. Anderson Cancer Center, 1996 - 1998 (Closed 4/13/98)

Protocols (cont.)

Collaborator, A Phase II Study of  - Difluoromethyl ornithine (DFMO) in Patients with Barrett’s Esophagus with Dysplasia, DM 98 - 204, University of Texas M.D. Anderson Cancer Center, Division of Medicine, 1999 – 5/02

Collaborator, Phase II Study of Preoperative CPT - 11/Cisplatin followed by Concurrent 5 - FU/Taxol and Radiotherapy in Patients with Potentially Resectable Carcinoma of the Esophagus or GE JunctionDM98 - 349, University of Texas M.D. Anderson Cancer Center, 1999–11/00

Collaborator, An Efficacy Study of Adenoviral Vector Expressing Wild type p53 (AD - p53) Administered Intralesionally as an Adjunct to Radiation Therapy in Patients with Non - Small Cell Cancer, GS 97 - 183, University of Texas M.D. Anderson Cancer Center, 1998–6/00

Principal Investigator, Lung Transplantation for End Stage Pulmonary Diseases,HSC - MD - 90 - 061, University of Texas Health Science Center at Houston, 1990–1993 (Closed)

Principal Investigator, Acute and Chronic Studies on Radioablation of Porcine Lung Parenchyma, IACUC 02 - 99 - 0112, University of Texas M. D. Anderson Cancer Center, 1999–2002

Study Co - Chairman, Measurement and Prediction of Postoperative Pain and Analgesic Requirement, ID00 - 370, University of Texas M. D. Anderson Cancer Center, 2001

Collaborator, Preoperative Cardiopulmonary Limit Reached (Closed) Function Testing to Predict Postoperative Morbidity and Mortality in the High Risk Patient with Resectable Lung Cancer, ID 89–009, University of Texas M.D. Anderson Cancer Center, 1989–1993

Principal Investigator, A Study of Lung Transplantation for the Cancer Patients: Treatment of Patients with Pulmonary Metastases from Osteogenic and Soft Tissue Sarcomas, ID89–030, University of Texas M.D. Anderson Cancer Center,1987–1988(Closed)

Collaborator, Phase III Double - Blind Randomized Trial of 13 - cis Retinoic Acid (13 - cRA) to Prevent Second Primary Tumors (SPTs) in Stage I Non - small Cell Lung Cancer, ID 91–025, University of Texas M.D. Anderson Cancer Center, 1992–9/98

Collaborator, Early Detection of Second Primary Lung Cancers By Sputum Cytology Immunostaining, ID 91–029, University of Texas M.D. Anderson Cancer Center,1992–6/00

Co - Chairman, Phase II study of combined modality treatment for resectable non - small cell superior sulcus tumor (SST), ID 92–038, University of Texas M.D. Anderson Cancer Center,1993 – 2004

Co - Investigator, An open study to assess concentration of CP - 99219 in whole lung tissue and serum after administration of multiple doses to patients undergoing thoracotomy,ID 94–046, University of Texas M.D. Anderson Cancer Center, 1994–1997

Collaborator, A phase I study of continuous infusion low dose paclitaxel and concurrent radiotherapy for unresectable esophageal cancer.ID 95–071, University of Texas M.D. Anderson Cancer Center, 1995–8/01

Principal Investigator, Phase I evaluation of single pass pulmonary perfusion with Adriamycin for sarcomatous (pulmonary) metastases,ID 95 – 219, University of Texas M.D. Anderson Cancer Center 1995–2004

Collaborator, A multi - center study of the correlation between the findings of atypical/malignant cells in sputum and fluorescence bronchoscopy using the LIFE Imaging System, and white light bronchoscopy, ID 95–230, University of Texas M.D. Anderson Cancer Center, 1996–10/98

Collaborator, Phase II Trial of Induction Paclitaxel/Carboplatin in Clinical Stage Ib (T2NO), Stage II (T1 - 2N1), and Selected Stage IIIa (T3NO - 1) Non - small Cell Lung Cancer (NSCLC), ID 96 - 038, University of Texas M.D. Anderson Cancer Center, 1996–1999 (Closed)

Protocols (cont.)

Collaborator, Phase I Study of Intratumoral E1A Gene Therapy for Patients with Unresectable or Metastatic Solid Tumors that Overexpress HER - 2/new, ID 96–117, University of Texas M.D. Anderson Cancer Center, 1996–1999 (Closed)

Study Chairperson, A Randomized Phase III Trial Surgery Alone or Surgery Plus Preoperative Paclitaxel/Carboplatin in Clinical Stage IB (T2N0), II (T1 - 2N1, T3N0) and Selected IIIA (T3N1) Non - Small Cell Lung Cancer (NSCLC), ID 99–400, University of Texas M.D. Anderson Cancer Center, 1999–2004

Collaborator, A Phase II Study of Preoperative 5 - FU, Taxol and Cisplatin Followed by Concurrent 5 - FU/Cisplatin and Radiotherapy in Patients with Potentially Resectable Carcinoma of the Esophagus or GE Junction, ID 96 - 189, University of Texas M.D. Anderson Cancer Center, 1996–1998 (Closed)

Collaborator, Phase II Study of Postoperative Adjuvant Therapy in Patients With Completely Resected Stage II and stage IIIa Non - small Cell Lung Cancer (NSCLC), RTOG 97–05, University of Texas M.D. Anderson Cancer Center,1997–7/98